Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Future Oncology (London, England)|March 17, 2009
Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectivesAnnie N Y Cheung, Hui Juan Zhang, Wei Chen Xue, et al.Frontiers in Oncology|November 25, 2021
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic TargetsJiangnan He, Michelle K Y Siu, Hextan Y S Ngan, et al.International Journal of Molecular Sciences|October 14, 2022
Molecular Biomarkers for the Early Detection of Ovarian CancerRuiqian Zhang, Michelle K Y Siu, Hextan Y S Ngan, et al.International Journal of Molecular Sciences|June 24, 2022
Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian CancersMingo M H Yung, Michelle K Y Siu, Hextan Y S Ngan, et al.Plos One|September 30, 2014
Downregulation of the gli transcription factors regulator Kif7 facilitates cell survival and migration of choriocarcinoma cellsJoanna Ho, Yanan Du, Oscar Gee-Wan Wong, et al.Journal of Andrology|June 27, 2003
Role of tissue inhibitor of metalloproteases-1 in junction dynamics in the testisDolores D Mruk, Michelle K Y Siu, Anne M Conway, et al.Oncotarget|March 25, 2014
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancerMichelle X Liu, Michelle K Y Siu, Stephanie S Liu, et al.Cancer Cell International|May 11, 2018
Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancerKaren K L Chan, Michelle K Y Siu, Yu-Xin Jiang, et al.International Journal of Molecular Sciences|December 11, 2022
New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal MetastasesShijie Zhan, Mingo M H Yung, Michelle K Y Siu, et al.The American Journal of Pathology|September 6, 2008
Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcomeMichelle K Y Siu, Esther S Y Wong, Hoi Yan Chan, et al.Pageof 5